Breaking News Instant updates and real-time market news.

THC

Tenet

$17.07

-0.08 (-0.47%)

11:50
09/13/17
09/13
11:50
09/13/17
11:50

Rumor: Tenet strength attributed to rumor of conference cancellation

Speculation that Tenet Healthcare (THC) may have canceled out of a planned conference appearance is being attributed as the reason the stock has moved off its earlier lows, according to trading contacts. The conference cancelation is unconfirmed, however, and it's not even clear if the company had any scheduled appearances. Shares of Tenet are off their earlier low of $16.84, trading down by about 4c to $17.11 at time of writing.

  • 02

    Oct

THC Tenet
$17.07

-0.08 (-0.47%)

09/06/17
CANT
09/06/17
NO CHANGE
CANT
Overweight
Irma threat a risk for HCA, public hospital peers, says Cantor
Cantor Fitzgerald analyst Joseph France noted that HCA Holdings (HCA), Community Health (CYH), LifePoint (LPNT), Tenet (THC) and Envision Healthcare (EVHC) all have business in Florida and Texas and are all down today on the potential threat from Hurricane Irma and the impact from Hurricane Harvey last week. HCA reports nearly half of its beds are in Florida and Texas while Envision has said in the past that more than half of its anesthesia business and about half of its legacy ER business is in those two states, noted France, who adds that Community Health, LifePoint and Tenet are less exposed to those states. The analyst keeps an Overweight rating on HCA shares.
09/01/17
MSCO
09/01/17
NO CHANGE
Target $15
MSCO
Equal Weight
Tenet turnaround may take several quarters to take root, says Morgan Stanley
Morgan Stanley analyst Zack Sopcak said Tenet's search for a new CEO and board changes are likely to drive short-term share gains, but he remains on the sidelines, citing the stock's 36% run-up in the two weeks prior to last night's announcement and his belief that it could be several quarters before a turnaround takes root. Sopcak keeps an Equal Weight rating and $15 price target on Tenet shares.
09/01/17
JPMS
09/01/17
NO CHANGE
JPMS
Neutral
JPMorgan cautions against chasing shares of Tenet
JPMorgan analyst Gary Taylor expects shares of Tenet to move higher today after the company announced CEO Trevor Fetter is stepping down and that it adopted a poison pill a day in advance of the Glenview standstill agreement expiration. In a research note titled "Less than Meets the Eye?," Taylor cautions investors against chasing the shares. There is limited ability now for activists to compel change, and a base-case sum-of-the-parts valuation analysis yields an $8-$19 share price, Taylor tells investors. He keeps a Neutral rating on Tenet.
08/28/17
JEFF
08/28/17
NO CHANGE
JEFF
Buy
HCA has 11% of its beds in Harvey impacted areas, says Jefferies
Jefferies analyst Brian Tanquilut points out that HCA Holdings (HCA) has 11% of its beds in areas impacted by severe weather from Hurricane Harvey. The analyst expects the hurricane to cause a "notable disruption," specifically for hospitals, physician offices, surgery centers, and labs. Investors are likely to take a long-term view of Hurricane Harvey, however, as it is a one-time issue and thus excluded from operating and financial results, Tanquilut tells investors in a research note. He sees both Tenet (THC) and Community Health (CYH) being minimally impacted from the storm. Envision Healthcare's (EVHC) AmSurg segment has three ambulatory surgery centers in the impacted markets, while Surgery Partners (SGRY) has only one facility in Houston, the analyst adds.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.